On Monday, August 12, 2019, MALDI–TOF M will be implemented at Cooper University Health Care’s Microbiology Section of the Pathology Department for bacterial and yeast identification.
MALDI is a more efficient technology that provides:
- Faster turnaround time for at least 24 hours of final bacterial and yeast identification results that you would be able to act upon.
- More accurate and precise identifications of bacteria and yeasts.
- New identifications that were not available before. MALDI will greatly increase our capability to identify organisms that we were not able to identify using previous methods.
- The ability for Epidemiology and Infection Prevention teams to act more quickly on results than traditional methods.
- Antibiotic stewardship improvement (i.e., the ability to tailor antibiotic therapy faster).
In addition to being a very lean technology that produces much less biohazard waste, MALDI is also approximately five to 10 times less expensive than our current technology for identification.
If you have questions or concerns, please contact Dejan Nikolic, MD, PhD, ASCP,
Medical Director of the Microbiology and Immunology Laboratory, at 856.342.2516 or via email: nikolic-dejan@cooperhealth.edu.